PCR And Realtime PCR Testing Market Is Predicted To Reach $16.38 Billion, Expanding At 8% CAGR Through 2030

 

What Are The Estimated Market Size And CAGR For The PCR And Realtime PCR Testing Market Between 2026 And 2030?
 The pcr and realtime pcr testing market size has grown strongly in recent years. It will grow from $11.12 billion in 2025 to $12.02 billion in 2026 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to expansion of molecular diagnostics adoption, increasing prevalence of infectious diseases, growth of genomics research activities, rising use of pcr in clinical diagnostics, expansion of academic research infrastructure.
 
 The pcr and realtime pcr testing market size is expected to see strong growth in the next few years. It will grow to $16.38 billion in 2030 at a compound annual growth rate (CAGR) of 8.0%. The growth in the forecast period can be attributed to increasing demand for personalized medicine, rising adoption of digital pcr technologies, expansion of decentralized diagnostic testing, growing investments in life science research, increasing use of pcr in oncology and genetic testing. Major trends in the forecast period include increasing adoption of high-throughput pcr platforms, rising demand for multiplex real-time pcr assays, growing integration of automated sample preparation systems, expansion of digital pcr applications, enhanced focus on contamination-free testing.
 
 Claim Your Free Report Sample Today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=2841&type=smp
 
 Which Primary Market Drivers Are Fueling Momentum In The PCR And Realtime PCR Testing Market?
 The rising approvals for personalized medicines are expected to propel the PCR And real-time PCR testing market going forward. Personalized medicines refer to therapeutic products or treatments tailored to the individual patient. They are designed based on a patient’s genetic, biomarker, phenotypic, or psychosocial characteristics that can predict an individual’s response to a treatment. PCR and Real-Time PCR in personalized medicine enables the precise identification of genetic variations, which helps tailor treatments to individual patient needs and optimize therapeutic outcomes. For instance, in February 2024, according to the Personalised Medicine Coalition, a US-based hospital and health care organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. Therefore, the rising approvals for personalized medicines drive the PCR And real-time PCR testing market. 
 
 What Major Market Segments Contribute To Shaping The Overall Framework Of The PCR And Realtime PCR Testing Market?
 The pcr and realtime pcr testing market covered in this report is segmented — 
 
 1) By Product: Consumables And Reagents, Instruments, Software And Services
 2) By Technology: Quantitative PCR, Digital PCR
 3) By Application: Clinical Diagnostics, Life Science Research, Industrial Applications, Other Applications
 4) By End-Use: Academic And Research Institutes, Pharmaceutical And Biotechnology, Clinical Diagnostics Labs And Hospitals, Other End Users
 
 Subsegments:
 1) By Consumables And Reagents: PCR Reagents, PCR Kits, PCR Primers And Probes, DNA And RNA Extraction Kits 
 2) By Instruments: PCR Machines/Amplifiers, Real-Time PCR Systems, Thermal Cyclers, Automated PCR Systems 
 3) By Software And Services: Data Analysis Software, PCR Software, Maintenance And Support Services, Training Services
 
 What Current Industry Trends Are Affecting The Performance Of The PCR And Realtime PCR Testing Market?
 Major companies operating in the PCR and real time PCR testing market are developing highly specific detection kits, such as variant targeted RT PCR assays, to better track viral evolution and support epidemiological surveillance. Variant-targeted RT PCR assays are molecular diagnostic tests designed to detect specific genetic mutations or variations within a virus, enabling precise identification of particular viral strains or sub-variants. For instance, in January 2023, Roche, a Switzerland based diagnostics company, introduced the VirSNiP SARS CoV 2 Spike F486P assay, a real time PCR test that specifically detects the F486P mutation in the XBB.1.5 Omicron sub-variant. This kit runs on standard real-time PCR platforms such as LightCycler 480 II and cobas z 480, and provides researchers with precise lineage differentiation to aid in variant monitoring. 
 
 Who Are The Established And Emerging Players Expanding Their Footprint In The PCR And Realtime PCR Testing Market?
 Major companies operating in the pcr and realtime pcr testing market are Abbott Laboratories, Agilent Technologies Inc., bioMérieux SA, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche Ltd., QIAGEN N.V., GenMark Diagnostics Inc., Thermo Fisher Scientific Inc., General Electric Company, Danaher Corporation, Becton Dickinson and Company, Luminex Corporation, Meridian Bioscience Inc., Fluidigm Corporation, RainDance Technologies Inc., BioFire Diagnostics LLC, Cepheid Inc., Illumina Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Promega Corporation, Takara Bio Inc., Twist Bioscience Corporation, Zymo Research Corporation, BioChain Institute Inc., BioLegend Inc., Bioo Scientific Corporation, Creative Diagnostics, Eurofins Scientific SE, Myriad Genetics Inc. 
 
 Get Your In-Depth PCR And Realtime PCR Testing Market Report Now:
 https://www.thebusinessresearchcompany.com/report/pcr-and-realtime-pcr-testing-global-market-report
 
 Which Regions Demonstrate The Highest Growth Momentum In The PCR And Realtime PCR Testing Market?
 Asia-Pacific was the largest region in the PCR and real-time PCR testing market in 2025. Western Europe was the second-largest region in the PCR and real-time PCR testing market. The regions covered in the pcr and realtime pcr testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company